The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen (Inst); Array BioPharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Genentech/Abbvie (Inst); GlaxoSmithKline (Inst); Merck Serono; MSD (Inst); Novartis (Inst); Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER
Research Funding - Amgen; Array BioPharma (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck Serono; Pierre Fabre (Inst); Roche (Inst); Sanofi/Aventis (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - SERVIER
Nivolumab (NIVO) + 5-fluorouracil/leucovorin/oxaliplatin (mFOLFOX6)/bevacizumab (BEV) versus mFOLFOX6/BEV for first-line (1L) treatment of metastatic colorectal cancer (mCRC): Phase 2 results from CheckMate 9X8.
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Fulgent Genetics; G1 THerapeutics; GlaxoSmithKline; Isofol Medical; Jazz Pharmaceuticals; Merck Serono; Oncocyte; Roche
Consulting or Advisory Role - Bayer; BMS; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono
 
Aparna Raj Parikh
Stock and Other Ownership Interests - C2i genomics
Consulting or Advisory Role - Checkmate Pharmaceuticals; Lilly; Natera; Pfizer; Roche/Genentech
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); PMV Pharma; PureTech (Inst)
 
David R. Spigel
Leadership - ASCO (Inst)
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Curio Science (Inst); EMD Serono (Inst); Evelo Therapeutics (Inst); Evidera (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Intellisphere (Inst); Ipsen (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Molecular Templates (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Research Funding - Aeglea Biotherapeutics (Inst); Agios (Inst); Apollomics (Inst); Arcus Biosciences (Inst); Arrys Therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); BIND Therapeutics (Inst); BioNTech (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Clovis Oncology (Inst); cyteir (Inst); Daiichi Sankyo (Inst); Denovo Biopharma (Inst); Eisai (Inst); Elevation Oncology (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Hutchison MediPharma (Inst); ImClone Systems (Inst); Immunogen (Inst); Incyte (Inst); Ipsen (Inst); Janssen Oncology (Inst); Kronos Bio (Inst); Lilly (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Molecular Partners (Inst); Molecular Templates (Inst); Nektar (Inst); Neon Therapeutics (Inst); Novartis (Inst); Novocure (Inst); Oncologie (Inst); Pfizer (Inst); PTC Therapeutics (Inst); PureTech (Inst); Razor Genomics (Inst); Repare Therapeutics (Inst); Rgenix (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech; Novartis
 
Allen Lee Cohn
Honoraria - Amgen
Expert Testimony - Department of Justice
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Lilly; Merck; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Mark D. Kochenderfer
No Relationships to Disclose
 
Elena Elez
No Relationships to Disclose
 
Spencer H. Shao
No Relationships to Disclose
 
Dustin A. Deming
Consulting or Advisory Role - Array BioPharma; Bayer; Lilly; Pfizer; Promega
Research Funding - Bayer; Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Millennium (Inst); Revolution Medicines (Inst)
 
Regan C. Holdridge
No Relationships to Disclose
 
Timothy Larson
No Relationships to Disclose
 
Eric Chen
Honoraria - Bayer; Eisai
Research Funding - AstraZeneca; Boston Biomedical; Bristol-Myers Squibb; Merck; Novartis; Zymeworks
 
Amit Mahipal
No Relationships to Disclose
 
Amit Mahipal
Honoraria - Eisai
Consulting or Advisory Role - QED Therapeutics
Research Funding - Taiho Pharmaceutical
 
Antonio Ucar
No Relationships to Disclose
 
Dana Cullen
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Edwina S Baskin-Bey
Leadership - Catalyst Clinical Research
Stock and Other Ownership Interests - Catalyst Clinical Research; Oncternal Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Geistlich Pharma; Green3Bio; Oncternal Therapeutics; Shasqi Inc.
Travel, Accommodations, Expenses - Geistlich Pharma
 
Jean-Marie Ledeine
Employment - Bristol-Myer Squibb
Stock and Other Ownership Interests - Bristol-Myer Squibb
 
Amy Hammell
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Avvinity; Bayer; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology; Seagen; Servier; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc
Other Relationship - Imedex; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource